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Abstract
Background: Arterial stiffness is a variable predictor of morbidity and mortality and a possible marker of vascular injury. 
Its non-invasive assessment by radial tonometry and analysis of the augmentation index (r-AI) allows identifying patients 
exposed to higher cardiovascular risk.
Objective: To analyze the influence of r-AI on clinical-biochemical variables and its influence on the prevalence of target-
organ damage in hypertensive patients.
Methods: 140 consecutive hypertensive patients, followed-up in an outpatient clinic, were analyzed in a cross-sectional 
study. Blood pressure (BP) levels and r-AI were obtained by applanation tonometry of the radial artery (HEM-9000AI, 
Onrom). The patients were allocated into r-AI tertiles (r-AI ≤ 85%; 85 < r-AI ≤ 97%; r-AI > 97%).
Results: The sample was predominantly composed of women (56.4%), mean age of 61.7 ± 11.7 years and body mass 
index 29.6 ± 6.1 Kg/m2. The highest tertile showed higher proportion of women (p = 0.001), higher systolic BP (p = 0.001) 
and pulse pressure (p = 0.014), and lower weight (p = 0.044), height (p < 0.001) and heart rate (p < 0.001). Multivariate 
analysis demonstrated that weight (β = -0.001, p = 0.017), heart rate (β = -0.001, p = 0.007) and central pressure
(β= 0.015, p < 0.001) correlated independently with r-AI. In logistic regression analyses, the 3rd r-AI tertile was associated 
to lower levels of diabetes (DM) (OR = 0.41; 95% CI 0.17-0.97; p = 0.042).
Conclusions: This study demonstrated that weight. heart rate and central BP were independently related to r-AI. 
(Arq Bras Cardiol 2011; 97(3) : 241-248)
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Introduction
Since the publication of the Conduit Artery Function 
Evaluation (CAFE) study1, the importance of assessment 
of arterial function and central blood pressure increased 
substantially. Despite the fact that brachial blood pressure 
is a powerful predictor of cardiovascular morbidity and 
mortality2, these measurements do not reflect the pressure in 
the central circulation. Recent evidence showed that central 
blood pressure is more relevant to cardiovascular outcomes 
than pressures in the brachial artery1,3,4.
It is well recognized that arterial stiffness parameters predict 
clinical outcomes, such as coronary artery disease5,6, stroke6, 
urinary albumin excretion7,8, progression of chronic kidney 
disease9, survival in end-stage renal disease10 and general 
cardiovascular risk11. The current standard for assessing this 
condition involves the measurement of several variables 
by noninvasive applanation tonometry, including the radial 
augmentation index (r-AI)12. r-AI, which is defined as an 
increase in pressure from the first systolic shoulder to the 
peak pressure of the aortic pressure waveform expressed as 
a percentage of peak pressure, has been correlated with left 
ventricular hypertrophy (LVH)13, coronary artery disease5, 
urinary albumin excretion14, cardiovascular events15,16 and all-
cause mortality16, representing an easier and quicker method 
to access the central pressure17,18.
Despite the fact that some variables such as age19,20, 
height11,18,20, heart rate11,19,21-24, gender11,18,19,21, systolic 
(SBP)20 and diastolic blood pressure (DBP)11,19,20 have been 
correlated with the augmentation index, this relationship 
needs to be better established. Therefore, this study aimed 
to analyze the influence of r-AI on the prevalence of target-
organ damage and to correlate this measure of arterial 
stiffness with clinical and biochemical variables in Brazilian 
hypertensive patients.
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Methods
Subjects
A total of 140 consecutive hypertensive patients, aged 
≥ 18 years, followed-up in an outpatient clinic from 
August/2009 to January/2010, were analyzed in a cross-
sectional study. The study was previously approved by 
the Research Ethics Committee of the institution and all 
participants signed an informed consent. Individuals were 
allocated to three groups according r-AI tertiles: Group 1 
(r-AI ≤ 85%) – 44 patients; Group 2 (85 < r-AI ≤ 97%) – 47 
patients; Group 3 (r-AI > 97%) – 49 patients. The exclusion 
criteria were: history of atrial fibrillation or frequent supra- 
or ventricular premature beats for which accurate radial 
waveforms could not be obtained by the system, age ≥ 70 
years and secondary hypertension.
Biochemical analysis, demographic data and target-organ 
damage 
Peripheral blood was drawn in fasting for biochemical 
analysis of serum creatinine, total cholesterol, HDL-cholesterol, 
triglycerides and glucose. LDL-cholesterol was calculated 
by the Friedewald formula. Urinary albumin excretion 
(UAE) was determined by 24-h urine sample, considering 
normoalbuminuria as UAE < 20 µg/min, microalbuminuria 
as UAE between 20 and 200 µg/min and macroalbuminuria 
as UAE ≥ 200 µg/min.
For the assessment of comorbidities, data regarding the 
presence of diabetes mellitus, medications in usage, body 
mass index [BMI = weight (kg) / height (cm)2], gender and 
other risk factors or necessary information were obtained 
from the medical record. Patients with diabetes mellitus (DM) 
were considered to be those who had been previously on 
hypoglycemic treatment or having fasting glucose levels ≥ 
126 mg/dL on at least two occasions. 
The estimated glomerular filtration rate (eGFR) was 
calculated using the abbreviated MDRD (Modification 
on Diet in Renal Disease) formula. Renal failure was 
defined as eGFR ≤ 60 mL/min. LVH was determined by 
echocardiography, the normal left ventricular mass index 
(LVMI) for men was < 103 g/m2 and for women < 89 g/m2, 
as suggested by the American Society of Echocardiography25.
Pulse wave and blood pressure analysis
Arterial pulse waveforms of the left radial artery were 
measured non-invasively by an automated tonometric 
system (HEM-9000AI; Omron Healthcare Co., Ltd., 
Kyoto, Japan) after 10 min of rest in a sitting position12. 
Pulse wave analyses were performed at least three times 
and the mean of measurements was analyzed. Radial 
arterial waveforms from this device, the first (P1) and late 
(second) systolic peaks (P2) were automatically identified 
using the fourth derivative wave as the second and third 
zero crossing points, respectively. Augmentation index (AI) 
was defined as the ratio of the height of P2 to that of P1. 
Brachial blood pressure (BP) and heart rate were measured 
simultaneously in the right brachium with an oscillometric 
device incorporated into the HEM-9000 AI. Late systolic 
BP in the radial artery (rSBP2), as an index of central BP26, 
was calculated by the following equation: rSBP2 = r-AI × 
(SBP−DBP) + DBP, in which SBP and DBP are brachial 
systolic and diastolic BP, respectively. All measurements 
were performed after at least 8-h fasting.
Statistical analysis
The calculated size of the sample, admitting a deviation 
of 1% to reject the hypothesis of nullity, was 122 patients. 
Previous studies exploring similar issues7,21 analyzed a sample 
size similar to this study. Descriptive analysis was performed 
for qualitative variables and quantitative results are presented 
as mean ± standard deviations. To compare the characteristics 
of patients ANOVA for quantitative and χ2 for qualitative 
variables were used. Univariate and multivariate analyses were 
performed to assess the determinants of r-AI using various 
clinical variables. The variables that were statistically significant 
(p < 0.05) in the univariate analysis were then evaluated in 
the multivariate analysis. All statistical analyses were performed 
using the Minitab 16.0 statistical software. For all tests, a p 
value < 0.05 was considered significant.
Results
Table 1 shows the clinical and biochemical characteristics 
of the patients according to the tertiles of r-AI. There was an 
increase in the proportion of women into the highest tertile, with 
increasing levels of SBP and pulse pressure. In contrast, there 
was a progressive reduction in weight, height and heart rate with 
increasing r-AI, with no significant differences for biochemical 
and echocardiographic parameters. There were no differences in 
the history of diabetes, renal failure, LVH or alterations in urinary 
albumin excretion among tertiles (Table 2), with the exception 
of a higher prevalence of LVH in the 3rd tertile of r-AI in relation 
to the 2nd tertile (p = 0.026).
Using logistic regression analyses (Table 3), the third tertile of 
r-AI were associated with lower risk of diabetes mellitus (OR = 
0.41; 95% CI 0.17-0.97; p = 0.042). There was no statistical 
significance (p > 0.05) for LVH and renal failure in the logistic 
regression.
Univariate (Table 4) and multivariate (Table 5) analyses were 
performed to assess factors determining r-AI. Univariate analysis 
showed that weight, height, gender, SBP, DBP, heart rate, pulse 
pressure, rSBP2 and glucose significantly correlated with r-AI. 
However, multivariate analysis demonstrated that only weight, 
heart rate and rSBP2 remained independently correlated with 
r-AI. Figures 1 and 2 show the relationship between r-AI with 
the variables that showed significance in the univariate analysis.
Discussion
In this study, we analyzed factors related to r-AI in a sample 
of hypertensive patients. The measure of arterial compliance 
through radial artery tonometry is a simple and easier method 
to assess arterial stiffness17,18. AI is strongly correlated with a 
previously validated estimate of arterial stiffness, pulse wave 
velocity (PWV)12,18. Its use to assess cardiovascular risk and 
drug effectiveness, as recently reported in the CAFE study, 
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gives additional data for the stratification of cardiovascular risk 
and allows clinicians to customize antihypertensive therapies 
specifically to a single patient1,2,17.
Recent reports show that AI is closely related with cardiovascular 
risk11,16. London et al16 found that the risk ratio for each 10% 
increase in AI was 1.51 (95% CI 1.23-1.86) for all-cause mortality 
and 1.48 (95% CI 1.16-1.90) for cardiovascular mortality in a 
sample of end-stage renal failure patients. Nürnberger et al11, 
on the other hand, found that AI significantly increased with 
increasing risk scores for cardiovascular disease. 
Some studies have shown values that could be considered 
normal for AI using limits of normality based on the 95% 
confidence interval. Wojciechowska et al26 in a European sample, 
proposed the value for peripheral AI of 90% for men and 100% 
for women. Shiburi et al27 in a study which included black South 
Africans, proposed the thresholds to diagnose increased arterial 
stiffness the value at age 30 years of 100% for peripheral AI, 
with adjustment by 10% for each decade that age differs from 
30 years. Li et al28 in a sample of 924 Chinese patients without 
cardiovascular disease demonstrated the approximate values for 
normal peripheral AI of 105% in a 40-year-old patient. Finally, 
Chung et al29 demonstrated in a Korean sample that peripheral 
AI of 100% may be the preliminary reference values. Despite 
these data, the estimation of reference values for peripheral AI in 
this Brazilian sample was not possible due to be a hypertensive 
sample with multiple comorbidities, which would prevent the 
validation of such data.
According to previous studies, r-AI was significantly 
related to weight, height11,18, gender11,18,19,21,28-30, heart 
rate11,19,21-23, SBP23,30 and DBP11,19, pulse pressure and glucose 
levels in univariate analyses. In this study, this association 
remained significant only for weight, height and heart rate in 
multivariate analyses. Body composition affects the timing of 
Table 1 – Comparison between clinical and biochemical variables among the tertiles of augmentation index 
Variable All(n=140)
1st Tertile
(n=44)a
2nd Tertile
(n=47)b
3rd Tertile
(n=49)c
p value*
(axbxc)
Age (years) 61.7 ± 11.7 60.4 ± 10.6 61.0 ± 12.4 63.5 ± 12.0 NS
Gender (Male/Female) 61/79 27/17† 23/24‡ 11/38 0.001
Weight (Kg) 78.4 ± 17.8 83.4 ± 21.7† 78.0 ± 15.4 74.3 ± 15.1 0.044
Height (m) 1.62 ± 0.09 1.66 ± 0.09† 1.63 ± 0.09‡ 1.59 ± 0.06 <0.001
Body mass index (Kg/m2) 29.6 ± 6.1 30.2 ± 7.3 29.4 ± 5.2 29.4 ± 5.9 NS
eGFR (ml/min) 55.9 ± 15.8 56.2 ± 16.5 55.8 ± 12.0 55.6 ± 18.5 NS
Diabetes (%) 47.3 56.8† 50.0 34.9 NS
Biochemical parameters
Glucose (mg/dL) 116.5 ± 49.9 129.9 ± 66.6 114.5 ± 41.1 106.4 ± 36.9 NS
HDL-cholesterol (mg/dL) 53.9 ± 13.8 56.1 ± 15.7 52.0 ± 14.7 53.9 ± 10.7 NS
LDL-cholesterol (mg/dL) 102.1 ± 34.5 102.0 ± 32.3 100.3 ± 37.3 104.0 ± 33.9 NS
Total cholesterol (mg/dL) 184.3 ± 46.6 185.9 ± 41.7 183.1 ± 56.4 183.2 ± 40.8 NS
Triglycerides (mg/dL) 136.9 ± 90.0 139.3 ± 65.1 146.4 ± 132.0 124.9 ± 49.9 NS
Creatinine (mg/dL) 1.4 ± 1.0 1.4 ± 0.4 1.3 ± 0.3 1.5 ± 1.6 NS
Urinary albumin excretion (µg/min) 110.6± 389.1 191.5 ± 630.1 72.2 ± 174.1 71.8 ± 191.1 NS
Tonometric parameters
SBP (mmHg) 131.9 ± 21.8 123.2 ± 17.0† 130.3 ± 20.6‡ 140.8 ± 23.6 0.001
DBP (mmHg) 73.4 ± 15.1 70.0 ± 11.2† 73.2 ± 16.0 77.4 ± 16.3 NS
Pulse pressure (mmHg) 58.2 ± 16.2 53.3 ± 12.1† 57.1 ± 16.5 63.4 ± 17.7 0.014
Heart rate (beats/min) 70.6 ± 13.7 77.7 ± 15.2†§ 67.4 ± 12.9 67.7 ± 11.0 <0.001
r-AI (%) 91.7 ± 13.3 76.3 ± 7.5†§ 92.1 ± 3.4‡ 105.4 ± 7.2 <0.001
rSBP1 (mmHg) 129.9 ± 20.9 123.7 ±16.9† 129.1 ± 20.6 136.0 ± 23.0 0.026
rSBP2 (mmHg) 125.0 ± 20.9 110.3±15.0†§ 123.9± 20.1‡ 138.4 ± 23.2 <0.001
Echocardiographic parameters
Left ventricular mass (g) 216.0 ± 79.9 218.5 ± 87.5 213.8 ± 77.6 216.9 ± 77.3 NS
Left ventricular mass index (g/m2) 117.3 ± 40.7 112.8 ± 50.0 111.8 ± 39.2 123.5 ± 37.2 NS
Values are expressed as numbers with the percentages in parentheses or mean ± SD. NS – Not significant (p>0.05); eGFR – estimated glomerular filtration rate; 
SBP – systolic blood pressure; DBP – diastolic blood pressure; r-AI – radial augmentation index; rSBP1 - First systolic BP in the radial artery; rSBP2 – Late systolic 
BP in the radial artery (central pressure); (*) ANOVA test; (†) 1st vs. 3rd tertile. p<0.05; (‡) 2nd vs. 3rd tertile. p<0.05; (§) 1st vs. 2nd tertile. p<0.05.
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arterial wave reflection, explaining the correlation between 
r-AI and weight and height31. Gatzka et al32 studied pairs of 
older men and women matched by age, BMI, and BP levels, 
and found that women had stiffer elastic arteries, suggesting 
an effect of female hormonal status in this relationship31. 
Other factors previously related to AI levels, such as 
age19,29,30, BMI30, creatinine clearance30, hiperlipidemia29,30 
and LVMI21 were not associated with r-AI levels in this 
sample. Aging is associated with histological changes in 
walls of systemic arteries, mainly in the intima and the in the 
media. These structural changes in the elastic arteries cause 
an increase in both stiffness and resistance31, explaining the 
relationship between AI and age.
There was no association between tertiles of r-AI and 
prevalence of the target-organ damage analyzed (renal 
failure, LVH and micro/macroalbuminuria). Despite this, 
there are reports that AI was associated with coronary artery 
disease5, urinary albumin excretion14 and LVH13, suggesting 
a relationship between AI and target-organ damage. In relation 
to LVH, we found a high prevalence in this sample possibly 
due to the cutoff point adopted by the American Society of 
Echocardiography for its diagnosis25. The attenuation of the 
Figure 1 – Relationship between radial augmentation index with height. weight. systolic and diastolic blood pressure.
Table 2 – Prevalence of target-organ damage according to tertiles of augmentation index
Variable 1
st Tertile
(n=44)a
2nd Tertile
(n=47)b
3rd Tertile
(n=49)c
p value*
(axbxc)
Renal dysfunction (%) 57.1 64.4 57.8 NS
Left ventricular hypertrophy (%) 69.7 66.7† 87.8† NS
Urinary albumin excretion
Normoalbuminuria (%) 42.9 61.9 56.8
NSMicroalbuminuria (%) 40.5 26.2 36.4
Macroalbuminuria (%) 16.7 11.9 6.8
NS – Not significant (p > 0.05); (*) χ2 test; (†) 2nd vs. 3rd tertile, p = 0.026.
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cushioning of elastic arteries amplifies the pressure pulsatility and 
increases the transmission of pulsatile energy to the peripheral 
microcirculation33. This occurs particularly in high-blood flow 
organs, such as brain and kidney, where pressure pulsatility 
penetrates further into the microcirculation, causing damage to 
these organs33,34. 
Table 3 – Logistic regression analyses for diabetes and target-organ damages and tertiles of augmentation index
Variable β SE Odds ratio (95% CI) Valor p
Diabetes mellitus
1st Tertile - - 1.00 -
2nd Tertile -0.274 0.428 0.76 (0.33-1.76) NS
3rd Tertile -0.898 0.441 0.41 (0.17-0.97) 0.042
Left ventricular hypertrophy
1st Tertile - - 1.00 -
2nd Tertile -0.139 0.518 0.87 (0.31-2.40) NS
3rd Tertile 1.411 0.609 3.13 (0.95-10.33) NS
Renal dysfunction
1st Tertile - - 1.00 -
2nd Tertile 0.307 0.440 1.36 (0.57-3.22) NS
3rd Tertile 0.025 0.433 1.03 (0.44-2.40) NS
NS – Not significant (p > 0.05).
Figure 2 – Relationship between radial augmentation index with heart rate. pulse pressure and glucose levels.
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In relation to glucose metabolism status, we found an inverse 
relation between glucose levels and r-AI in the univariate 
analysis. However, when multivariate analyses are performed, 
this relationship is not present. Further, in the logistic regression, 
the 3rd tertile of r-AI was associated with lower prevalence of 
DM (OR = 0.41, 95% CI 0.17-0.97, p = 0.042). Studies of 
the association between type 2 DM and AI are inconclusive. 
Similarly to our results, Tomita et al35 found in a sample of type 
2 diabetic patients a negative association of r-AI to plasma 
glucose and HbA1c. Lacy et al36 in a multiple regression analysis 
revealed that DM is a significant determinant of PWV, but not 
of AI. Guiadoni et al37 also did not found any difference for AI 
between normotensive patients with and without metabolic 
syndrome. This same trend was observed by Wilhelm et al in a 
comparison between type 2 DM and controls38.  On the other 
hand, Wilkinson et al39 showed that AI was significantly high in 
diabetic patients compared with controls matched by sex, age, 
weight and height. Despite the fact that there was no difference 
for AI between patients with impaired glucose metabolism and 
normoglicemic controls, Schram et al40 found a higher aortic AI in 
patients with DM compared to normoglicemic controls. However, 
our study cannot provide evidence for these mechanisms. The 
relationship between r-AI and lower prevalence of DM may have 
simply coexisted.
This study has some limitations that deserve to be mentioned. 
Firstly, its cross-sectional design and relative small number of 
patients does not allow the investigation of the relationship 
between AI and primary outcomes (stroke and myocardial 
infarction). Secondly, the AI could have been influenced by 
heart rate. Therefore, although we did not adjust AI for heart 
rate, we measured it after 10 minutes of rest. Thirdly, due the 
fact of our service is a specialized outpatient clinic, we could not 
assess patients with newly diagnosed hypertension and without 
antihypertensive treatment for this study.
In conclusion, in our country, this is one of the pioneering 
studies evaluating the importance of central BP and markers of 
arterial stiffness (r-AI) in Brazilian hypertensive individuals. In this 
sample, weight, heart rate and central BP were independently 
related to r-AI. 
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Table 4 – Correlation coefficients of augmentation index with 
clinical-biochemical variables
Variable r p value
Age (years) 0.116 NS
Weight (Kg) -0.325 < 0.001
Height (m) -0.389 < 0.001
Gender (female) 0.343 < 0.001
Body mass index (Kg/m2) -0.143 NS
SBP (mm Hg) 0.275 0.002
DBP (mm Hg) 0.187 0.036
HR (beats/min) -0.298 0.001
rSBP2 (mmHg) 0.477 < 0.001
PP (mm Hg) 0.197 0.027
Total cholesterol (mg/dL) -0.020 NS
LDL-cholesterol (mg/dL) -0.020 NS
HDL-cholesterol (mg/dL) -0.011 NS
Triglycerides (mg/dL) -0.033 NS
Creatinine (mg/dL) 0.041 NS
Glucose (mg/dL) -0.203 0.020
Urinary albumin excretion (µg/min) -0.154 NS
Creatinine clearance (ml/min) -0.022 NS
Left ventricular mass (g) -0.008 NS
Left ventricular mass index (g/m2) 0.130 NS
SBP – systolic blood pressure; DBP – diastolic blood pressure; HR – Heart 
rate; rSBP2 – Late systolic BP in the radial artery (central pressure); PP – 
Pulse pressure; NS – Not significant (p > 0.05).
Table 5 – Multivariate relation between augmentation index and clinical-
biochemical variables
Variable ß SEβ p value
Weight (Kg) -0.001 0.001 0.017
Height (m) -0.019 0.089 NS
Gender 0.010 0.015 NS
SBP (mm Hg) -0.011 0.020 NS
DBP (mm Hg) -0.002 0.020 NS
HR (beats/min) -0.001 0.001 0.007
PP (mm Hg) -0.001 0.020 NS
rSBP2 (mmHg) 0.015 0.001 < 0.001
Glucose (mg/dL) 0.001 0.001 NS
SBP – systolic blood pressure; DBP – diastolic blood pressure; HR – Heart 
rate; PP – Pulse pressure; rSBP2 – Late systolic BP in the radial artery 
(central pressure); NS – Not significant (p > 0.05). 
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